Yingzhong Li
President & Chief Executive Officer SunVax mRNA Therapeutics
Seminars
Tuesday 29th September 2026
Panel Discussion: Advancing Purification Strategies for Circular & Self-Amplifying RNA to Improve Purity, Boost Yield, & Enable Scalable, Regulatory-Ready Manufacturing
2:30 pm
Key questions include:
- Are current circRNA purification strategies fundamentally overcomplicated – and where can we simplify without compromising quality?
- How do you balance purity, yield, and scalability when designing purification processes for clinical and commercial manufacturing?
- What will define a “fit-for-purpose” purification platform for circRNA as the field moves toward first-in-human and beyond?
Wednesday 30th September 2026
Overcoming CMC & Operational Challenges to Enable Successful saRNA Development
10:30 am
- Navigating key manufacturing challenges in saRNA development, including scalability, process robustness, and product quality considerations
- Evaluating and selecting the right CRO partners to support efficient development, tech transfer, and long-term program success
- Applying effective cross-functional project management strategies to streamline timelines, communication, and CMC execution across saRNA programs
